CC-94676 or BMS-986365 is a highly selective AR degrade for castration resistant prostate cancer, the first good results were reported in January this year, but in September we will get more news at ESMO 2024
Funny thing on my last appointment with my MO at Medical College of WI he told me he is going to this conference and I will be there same time on holiday. So we are meeting up for dinner! That is why hotel rooms are over $500/night
In your wide reading, how is metastatic castrate resistance defined? More specifically, does merely rising PSA qualify, or do scans have to show either growth in existing Mets, or the appearance of new Mets?
I ask because some doctors apparently draw conclusions based solely on rising PSA without radiographic progression.
I must say it's a debated topic, especially with evolving measurement techniques and tools. Technically CR means that despite the very low testosterone in your blood, you have an increased activity if the cancer, that can be measured by PSA or PSADT but also via radiographic progression without PSA changes.
Yes, I understand that progression on scans without rising PSA is serious. But the opposite--rising PSA but no visible progression-especially if after rises PSA is still 5 or less- is more puzzling.
Could be a factor, say, in whether chemo will work effectively at a particular moment.
I guess this topic applies more to men who still have their prostate never having had RO or radiation.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.